Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125523531 | 12552353 | 1 | I | 20160705 | 20160713 | 20160713 | EXP | CA-GLAXOSMITHKLINE-CA2016GSK099380 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160713 | CN | US | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125523531 | 12552353 | 1 | PS | WELLBUTRIN XL | BUPROPION HYDROCHLORIDE | 1 | Oral | 150 MG, BID | U | 18644 | 150 | MG | TABLET | BID | |||||
125523531 | 12552353 | 2 | SS | ACETAMINOPHEN + CODEINE PHOSPHATE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | 2 DF, TID | U | 0 | 2 | DF | TID | ||||||
125523531 | 12552353 | 3 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | 0.5 MG, TID | U | 0 | .5 | MG | TID | |||||||
125523531 | 12552353 | 4 | SS | CIPRALEX | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG, UNK | U | 0 | 20 | MG | |||||||
125523531 | 12552353 | 5 | SS | TEMAZEPAM. | TEMAZEPAM | 1 | Oral | 30 MG, 1D | U | 0 | 30 | MG | QD | ||||||
125523531 | 12552353 | 6 | SS | DOMPERIDONE | DOMPERIDONE | 1 | 10 MG, BID | U | 0 | 10 | MG | BID | |||||||
125523531 | 12552353 | 7 | SS | FERROUS SULFATE. | FERROUS SULFATE | 1 | 300 MG, TID | U | 0 | 300 | MG | TID | |||||||
125523531 | 12552353 | 8 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
125523531 | 12552353 | 9 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, BID | U | 0 | 600 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125523531 | 12552353 | 1 | Product used for unknown indication |
125523531 | 12552353 | 2 | Product used for unknown indication |
125523531 | 12552353 | 3 | Product used for unknown indication |
125523531 | 12552353 | 4 | Product used for unknown indication |
125523531 | 12552353 | 5 | Product used for unknown indication |
125523531 | 12552353 | 6 | Product used for unknown indication |
125523531 | 12552353 | 7 | Product used for unknown indication |
125523531 | 12552353 | 8 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125523531 | 12552353 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125523531 | 12552353 | Condition aggravated | |
125523531 | 12552353 | Dehydration | |
125523531 | 12552353 | Dysphagia | |
125523531 | 12552353 | Mental disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |